Company Overview and News

 
MOD Resources extremely undervalued say analysts based on pre-feasibility study

2018-04-03 proactiveinvestors.com.au
MOD Resources Ltd’s (ASX:MOD) environmental management plan has been approved, paving the way for drilling at its T3 copper deposit in Botswana.
Upvote Downvote

 
MOD plans to ‘turbo charge’ copper projects

2018-03-06 australianmining.com.au
MOD Resources is aiming to “turbo charge growth” at its assets in the Kalahari copper belt in Botswana, Africa.
Upvote Downvote

 
MOD Resources raising $18 mln for copper project in Botswana

2018-03-06 proactiveinvestors.com.au
MOD Resources Ltd (ASX:MOD) has received firm commitments to raise $12 million in an oversubscribed share placement to institutional and sophisticated investors at $0.047 each.
Upvote Downvote

 
MOD Resources Ltd raising $18 mln for copper project in Botswana

2018-03-06 proactiveinvestors.com.au
MOD Resources Ltd (ASX:MOD) has received firm commitments to raise $12 million in an oversubscribed share placement to institutional and sophisticated investors at $0.047 each.
Upvote Downvote

 
Mod raises $18m

2018-03-06 businessnews.com.au
Copper explorer MOD Resources has tapped investors for $18.3 million, with the proceeds set to be used on exploration work at its T3 and T20 Dome projects in Botswana.
Upvote Downvote

 
MOD Resources (MDRUF) Presents At 121 Mining Investment - Cape Town - Slideshow

2018-02-06 seekingalpha
The following slide deck was published by MOD RESOURCES LIMITED ORD in conjunction with this event.
Upvote Downvote

 
Mod releases positive PFS

2018-01-31 businessnews.com.au
Copper explorer MOD Resources has released a favourable pre-feasibility study for an open-pit mine at its T3 project in Botswana, which has an estimated annual free cash flow of $US77 million ($95 million).
Upvote Downvote

 
Mod Resources looks to extend the mine life of T3 copper project

2018-01-05 proactiveinvestors.com.au
T3 is part of the joint venture (JV) between MOD (70%) and AIM listed Metal Tiger Plc (30%).
Upvote Downvote

 
MOD Resources (MDRUF) Presents At 121 Mining Investment London Spring 2017 Conference - Slideshow

2017-11-27 seekingalpha
The following slide deck was published by MOD RESOURCES LIMITED ORD in conjunction with this event.
Upvote Downvote

 
Drilling/Production Report

2017-08-07 londonstockexchange
Metal Tiger plc (LON:MTR) the London Stock Exchange AIM listed investor in strategic natural resource opportunities is pleased to provide an update regarding the Company’s Joint Venture (“JV”) project with partners MOD Resources (ASX:MOD) in the Kalahari Copper Belt in Botswana (70% MOD Resources / 30% Metal Tiger). Metal Tiger also holds 91,795,214 MOD shares, equivalent to 4.86% of MOD’s issued share capital and 1,541,667 MOD warrants at an exercise price of 6 cents (Australian).
Upvote Downvote

 
Botswana Copper/Silver - AEM Geophysics Anomalies

2017-07-21 londonstockexchange
Metal Tiger plc (LON:MTR) the London Stock Exchange AIM listed investor in strategic natural resource opportunities is pleased to provide an update regarding the Company's Joint Venture ("JV") project with partners MOD Resources (ASX:MOD) in the Kalahari Copper Belt in Botswana (70% MOD Resources / 30% Metal Tiger). Metal Tiger also holds 91,795,214 MOD shares, equivalent to 4.86% of MOD's issued share capital and 1,541,667 MOD warrants at an exercise price of 6 cents (Australian).
Upvote Downvote

 
Botswana Copper/Silver Project - T3 Progress Update

2017-07-17 londonstockexchange
Metal Tiger plc (LON:MTR) the London Stock Exchange AIM listed investor in strategic natural resource opportunities is pleased to provide an update regarding the Company’s Joint Venture (“JV”) project with partners MOD Resources (ASX:MOD) in the Kalahari Copper Belt in Botswana (70% MOD Resources / 30% Metal Tiger). Metal Tiger also holds 91,795,214 MOD shares, equivalent to 4.86% of MOD’s issued share capital and 1,541,667 MOD warrants at an exercise price of 6 cents (Australian).
Upvote Downvote

 
MOD Resources Investment Update

2017-07-13 londonstockexchange
Metal Tiger plc (LON:MTR) the London Stock Exchange AIM quoted investor in strategic natural resource opportunities is pleased to announce an update with regard to the Company’s investment in MOD Resources (ASX:MOD).
Upvote Downvote

 
Botswana Copper/Silver Project - Airborne EM Survey & Permitting Update

2017-07-06 londonstockexchange
Metal Tiger plc (LON:MTR) the London Stock Exchange AIM listed investor in strategic natural resource opportunities is pleased to provide an update regarding the Company’s Joint Venture (“JV”) project with partners MOD Resources (ASX:MOD) in the Kalahari Copper Belt in Botswana (70% MOD Resources / 30% Metal Tiger). Metal Tiger also holds 91,121,626 MOD shares, equivalent to 4.88% of MOD’s issued share capital and 1,541,667 MOD warrants at an exercise price of 6 cents (Australian).
Upvote Downvote

 
Mod sells gold project for $4m

2017-07-03 businessnews.com.au
Copper explorer MOD Resources has entered into an agreement to sell its Sams Creek gold project in New Zealand to a company planning to list on the ASX.
Upvote Downvote

Related Articles

GNCA: Genocea Biosciences Analysis and Research Report

2018-04-25 - Asif

Overview Genocea Biosciences is a biopharmaceutical company that discovers and develops novel cancer vaccines. The company use its proprietary discovery platform, ATLAS, to recall a patient’s pre-existing CD4+ and CD8+ T cell immune responses to their tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. The company believe that using ATLAS to identify antigens for inclusion in cancer vaccines could lead to more immunogenic and efficacious cancer vaccines. In September 2017, the company announced a strategic shift to immuno-oncology and a focus on the development of neoantigen cancer vaccines. Currently, all of its research programs and product candidates in active development are at the preclinical stage. The company's most advanced program is its preclinical immuno-oncology program, GEN-009, a neoantigen cancer vaccine. The GEN-009 program uses ATLAS to identify patient neoantigens, or newly formed anti...

AMZN: Amazon.com, Inc Analysis and Research Report

2018-04-25 - Asif

Overview Amazon.com opened its virtual doors on the World Wide Web in July 1995. The company seek to be Earth’s most customer-centric company. Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. In each of its segments, the company serve its primary customer sets, consisting of consumers, sellers, developers, enterprises, and content creators. In addition, the company provide services, such as advertising services and co-branded credit card agreements. Amazon has organized its operations into three segments: North America, International, and Amazon Web Services (“AWS”). These segments reflect the way the Company evaluates its business performance and manages its operations. Additional information on its operating segments and its net sales is contained in Item 8 of Part II, “Financial Statements and Supplementary Data—Note 11—Segment Information.” The compan...

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...